Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-072217
Filing Date
2025-07-30
Accepted
2025-07-30 17:00:26
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522008-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2522008-1_3aseq1.xml 3/A 5810
2 EXHIBIT 24 tm2522008d1_ex24.htm EX-24 4619
  Complete submission text file 0001104659-25-072217.txt   11837
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Crum Demetris D (Reporting) CIK: 0002078592 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-35565 | Film No.: 251167972